Figure 6. DFMO and Trimer PTI co-treatment reduces the immunosuppressive and pro-tumorigenic cells populations.

Upon sacrifice, tumors were excised from CT26.CL25-tumor bearing mice and processed for analysis by flow cytometry. CD45⁺ tumor cells were analyzed for the percentage of the indicated cell subpopulations. n = 5-10 mice per group; ^* = p ≤ 0.05 and # = p ≤ 0.01 compared to indicated group.